Submitted on March 4, 2008
Revised on April 23, 2008
Accepted on April 25, 2008
an apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients
Clive R Pullinger, Bradley E Aouizerat, Irina Movsesyan, Vincent Durlach, Eric J. Sijbrands, Katsuyuki Nakajima, Annie Poon, Geesje M. Dallinga-Thie, Hiroaki Hattori, Lauri L. Green, Pui-Yan Kwok, Richard J. Havel, Philip H. Frost, Mary J. Malloy, and John P. Kane
Cardiovascular Research Institute, UCSF, San Francisco, CA 94143-0130
Corresponding Author: clive.pullinger{at}ucsf.edu
Apolipoprotein A-V (apoA-V) is an important regulator of plasma levels of triglyceride (TG) in mice. In humans, APOA5 genetic variation is associated with TG in several populations. In this study we determined the effects of the p.185Gly>Cys (c.553G>T; rs2075291) polymorphism on plasma TG levels in subjects of Chinese ancestry living in the United States, and in a group of non-Chinese Asian ancestry. The frequency of the less common cysteine allele was four-fold higher (15.1% versus 3.7%) in Chinese high-TG subjects compared to a low-TG group (2= 20.2; p<0.0001) corresponding with a 4.45 times higher risk of hypertriglyceridemia (95% confidence interval 2.18-9.07; p<0.001). These results were replicated in the non-Chinese Asians. Heterozygosity was associated, in the high-TG group, with a doubling of TG (p<0.001); mainly VLDL TG (p=0.014). All eleven TT homozygotes had severe hypertriglyceridemia with mean TG of 2292 ± 447 mg/dl. Compared to controls, carriers of the T allele had lower post-heparin lipoprotein lipase activity but not hepatic lipase activity. In Asian populations this common polymorphism can lead to profound adverse effects on lipoprotein profiles with homozygosity accounting for a significant number of cases of severe hypertriglyceridemia. This specific apoA-V variant has a pronounced effect on triglyceride metabolism, the mechanism of which remains to be elucidated.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
